Images List Premium Download Classic

Quinoline

Quinoline-related patent applications - as published by the U.S. Patent and Trademark Office (USPTO).


loading
Life-extending agent, life extension method using the life-extending agent, novel dual oxidase activator, method for ...
Mitsubishi Gas Chemical Company, Inc.
October 12, 2017 - N°20170291898

The present invention provides a life-extending agent comprising pyrroloquinoline quinone and/or a derivative of the pyrroloquinoline quinone.
Corneal thickness adjustment agent
Kowa Company, Ltd.
October 12, 2017 - N°20170290840

The present invention provides a novel corneal thickness modulating agent. The present invention pertains to a corneal thickness modulating agent containing 1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine or a salt thereof or a solvate thereof.
Tetrahydroisoquinoline derived prmt5-inhibitors
Ctxt Pty Ltd
October 05, 2017 - N°20170283407

A compound of formula (i) wherein: r1 is optionally one or more halo or methyl groups; r2a and r2b are independently selected from the group consisting of: (i) f; (ii) h; (iii) me; and (iv) ch2oh; r2c and r2d are independently selected from the group consisting of: (i) f; (ii) h; (iii) me; and (iv) ...
Quinoline Patent Pack
Download 195+ patent application PDFs
Quinoline Patent Applications
Download 195+ Quinoline-related PDFs
For professional research & prior art discovery
inventor
  • 195+ full patent PDF documents of Quinoline-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Quinolines and their use for treating endoplasmic reticulum stress-caused diseases
Eiger Biopharmaceuticals, Inc.
October 05, 2017 - N°20170281611

Provided herein are quinolines, e. G., a compound of formula (i) or (ib), pharmaceutical compositions thereof, and methods of their use for treating, preventing, or ameliorating one or more symptoms of an endoplasmic reticulum stress-caused disease. Also provided herein are methods of their use for reducing endoplasmic reticulum stress and modulating the activity of a sarcoplasmic/endoplasmic reticulum ca2+ atpase.
Isoquinoline derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2
Merck Sharp & Dohme Corp.
September 28, 2017 - N°20170275274

The present invention relates to a compound represented by formula i: and pharmaceutically acceptable salts thereof. The compounds of formula i are inhibitors of diacylglyceride o-acyltransferase 2 (“dgat2”) and may be useful in the treatment, prevention and suppression of diseases mediated by dgat2. The compounds of the present invention may be useful in the treatment of hepatic ...
Asymmetric bisaminoquinolines and bisaminoquinolines with varied linkers as autophagy inhibitors for cancer and other therapy
The Trustees Of The University Of Pennsylvania
September 28, 2017 - N°20170275252

The invention provides novel asymmetric and symmetric bisaminoquinolmes and related compounds, methods of treatment and syntheses. The novel compounds exhibit effective anticancer activity and are useful in the treatment of a variety of autophagy-related disorders.
Quinoline Patent Pack
Download 195+ patent application PDFs
Quinoline Patent Applications
Download 195+ Quinoline-related PDFs
For professional research & prior art discovery
inventor
  • 195+ full patent PDF documents of Quinoline-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2
Merck Sharp & Dohme Corp.
September 28, 2017 - N°20170273966

The present invention relates to a compound represented by formula i:and pharmaceutically acceptable salts thereof. The compounds of formula i are inhibitors of diacylglyceride o-acyltransferase 2 (“dgat2”) and may be useful in the treatment, prevention and suppression of diseases mediated by dgat2. The compounds of the present invention may be useful in the treatment of hepatic ...
Tetrahydroisoquinoline derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2
Merck Sharp & Dohme Corp.
September 28, 2017 - N°20170273965

The present invention relates to a compound represented by formula (i): and pharmaceutically acceptable salts thereof. The compounds of formula (i) are inhibitors of diacylglyceride o-acyltransferase 2 (“dgat2”) and may be useful in the treatment, prevention and suppression of diseases mediated by dgat2. The compounds of the present invention may be useful in the treatment of hepatic ...
Process for preparing synthetic intermediates for preparing tetrahydroquinoline derivatives
Dezima Pharma B.v.
September 21, 2017 - N°20170267640

The present invention relates to a process for the preparation of synthetic intermediates which may be used in the preparation of tetrahydroquinoline derivatives, which derivatives have an inhibitory activity against cholesteryl transfer protein (cetp), show effects of increasing hdl cholesterol level and decreasing ldl cholesterol level, and can be used for the treatment and/or prevention of diseases such as ...
Pyrimido[4,5-b]quinoline-4,5(3h,10h)-diones
Novartis Ag
September 21, 2017 - N°20170266189

The invention relates to compound of the formula (i); or a salt thereof, wherein the substituents are as defined in the specification; to its preparation, to its use as medicament and to medicaments comprising it.
Pharmaceutical product
Kowa Company, Ltd.
September 21, 2017 - N°20170266080

A technique is provided for suppressing discoloration of an aqueous composition containing a halogenated isoquinoline derivative during preservation at high temperature. A pharmaceutical preparation obtained by storing an aqueous composition comprising a compound represented by formula (1), wherein x represents a halogen atom, or a salt thereof, or a solvate of the compound or the salt thereof, in a container made ...
Toll-like receptor-7 and -8 modulatory 1h imidazoquinoline derived compounds
The University Of Kansas
September 14, 2017 - N°20170260184

The present disclosure provides novel imidazoquinoline derived compounds, derivatives thereof, analogues thereof, and pharmaceutically acceptable salts thereof, and methods of making and using such compounds. The present disclosure also provides tlr7 agonists and tlr7/tlr8 dual agonists, probes, tissue-specific molecules, adjuvants, immunogenic compositions, therapeutic compositions, and self-adjuvanting vaccines including the imidazoquinoline derived compounds, derivatives thereof, analogues thereof, and pharmaceutically acceptable ...
Bi-benzyl isoquinoline derivative, preparation method and use thereof in hepatopathy treatment and prevention
Versitech Ltd.
September 14, 2017 - N°20170260161

The invention disclosed a compound of general formula (i), a single stereoisomer thereof, a mixture of stereoisomers thereof, and a prodrug, pharmaceutically acceptable salt and metabolite thereof, x1, x2, x3, x4, r1, r2, x, y and z being as defined in the present invention.
Quinoline Patent Pack
Download 195+ patent application PDFs
Quinoline Patent Applications
Download 195+ Quinoline-related PDFs
For professional research & prior art discovery
inventor
  • 195+ full patent PDF documents of Quinoline-related inventions.
  • Exact USPTO filing data with full-text, images, drawings & claims.
  • Index pages: Table View and Image-Grid View layouts. All images in each PDF.
Substituted n,2-diarylquinoline-4-carboxamides and the use thereof as anti-inflammatory agents
Bayer Pharma Aktiengesekkschaft
September 14, 2017 - N°20170260140

The present application relates to novel substituted n,2-diarylquinoline-4-carboxamide derivatives, to processes for preparation thereof, to the use thereof alone or in combinations for treatment and/or prevention of diseases, and to the use thereof for production of medicaments for treatment and/or prevention of diseases, especially for treatment and/or prevention of fibrotic and/or inflammatory disorders.
Novel 5-aminotetrahydroquinoline-2-carboxylic acids and their use
Bayer Pharma Aktiengesellschaft
September 14, 2017 - N°20170260139

The present application relates to novel 5-amino-5,6,7,8-tetrahydroquinoline-2-carboxylic acids, to processes for their preparation, to their use for the treatment and/or prevention of diseases, and to their use for producing medicaments for the treatment and/or prevention of diseases, especially for the treatment and/or prevention of cardiovascular and cardiopulmonary disorders.
Use of pyrroloquinoline compounds to kill clinically latent microorganisms
Bayer Pharma Aktiengesellschaft
September 14, 2017 - N°20170258784

Wherein r1, r2, r3 and x have meanings given in the description, for the preparation of a medicament for killing clinically latent microorganisms. There is also provided the use of compounds of formula i for treating microbial infections, as well as certain compounds of formula i per se.
Noscapinoid-producing microbes and methods of making and using the same
The Board Of Trustees Of The Leland Stanford Junior University
September 07, 2017 - N°20170253898

Engineered non-plant cells that produce a benzylisoquinoline alkaloid product that is a derivative of canadine along a metabolic pathway that converts canadine, or an analog of canadine, to a noscapinoid product are provided. Methods of culturing engineered non-plant cells that produce a noscapinoid product and pharmaceutical compositions are also provided.
Herbicidal quinolines
Syngenta Participations Ag
September 07, 2017 - N°20170251670

The present invention relates to compounds of formula (i), or an agronomically acceptable salt of said compounds wherein a1a, a1b, r1, r2, r3, r4, r5 and r6 are as defined herein. The invention further relates to herbicidal compositions which comprise a compound of formula (i), and to their use for controlling weeds, in particular in crops of useful ...
Solid pharmaceutical composition
Syngenta Participations Ag
August 31, 2017 - N°20170246160

[solution] this solid pharmaceutical composition is obtained by using crystals (b-form crystals) of a hydrate of 7-{(3s,4s)-3-[(cyclopropylamino)methyl]-4-fluoropyrrolidine-1-yl}-6-fluoro-1-(2-fluoroethyl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid hydrochloride, having peaks at 9. 4 and 17. 7 degrees (±0. 2 degrees for each angle) as 2θ diffraction angles in x-ray powder diffraction using cukα ...
Detergents and cleaning agents having improved performance
Henkel Ag & Co. Kgaa
August 24, 2017 - N°20170240847

The present invention relates to the use of 8-hydroxyquinoline sulfonic acids in detergents and cleaning agents for improving the washing or cleaning performance with respect to bleachable stains.
Pyrroloquinoline derivatives as 5-ht6 antagonists, preparation method and use thereof
Universite De Montpellier
August 24, 2017 - N°20170239237

This invention concerns pyrroloquinoline derivatives as antagonists of 5-ht6 receptors, to methods for the preparation of these compounds and to novel intermediates useful for their synthesis. The invention also relates to the uses of such compounds and compositions, particularly their use in administering them to patients to achieve a therapeutic effect in schizophrenia, anxiety, depression, maniac depression, epilepsy, obsessive compulsive ...
Loading